About Us
- About Us
  - - - Historical Innovation
        View our Interactive Timeline
Therapies
- Therapies
  - - - We Are Committed to our Patients
        Clinical Trials
Research
- Research
  - - - Meet Our Scientists
        Patrick
        Gene
        Regina
Partnering
- Partnering
  - - - What we are looking for
    - - We are Committed to Success through Partnerships
Responsibility
- Responsibility
  - - - A Growing Community of Good Citizens
        Read the PharmaVoice Article
Media
- Media
Careers
- Careers
  - - - Learn more about working at EMD Serono
        Meet our Employees

What is interesting about EMD Serono's pipeline?

Nuwan, Associate Director Neurodegenerative Diseases, Global Clinical Development Unit: "Collectively...more

Nuwan, Associate Director Neurodegenerative Diseases, Global Clinical Development Unit: "Collectively the portfolio of EMD Serono pipeline compounds, both in late stage and early discovery can be considered transformative therapies. They have the potential to dramatically change the lives of patients suffering from debilitating diseases for the better."

What is it like to be a scientist at EMD Serono?

Gaianne, Associate Scientist, Compound Management: "It is rewarding to work in an environment that bridges...more

Gaianne, Associate Scientist, Compound Management: "It is rewarding to work in an environment that bridges the connection between the chemists and the scientists who test each compound to discover the next drug that could potentially eradicate cancer."

Topic

Research

Living the science, delivering the promise

Our globally integrated R&D organization deploys more than 2,300 professionals worldwide with four main hubs in Geneva, Darmstadt, Boston and Beijing. By structuring our activities around highly connected hubs as centers of excellence, we strengthen internal networking and facilitate external partnerships.

Our objective is to discover novel new therapeutic molecules to bring to the clinic as quickly as possible in order to confirm the mode of action and reach proof-of-concept in patients. Our highly specialized research and clinical development teams evaluate potential therapeutic compounds with the goal of developing therapies for the treatment of diseases, such as multiple sclerosis and cancer.
The global discovery pipeline currently includes approximately 70 projects prior to first-in-man studies.Worldwide, we are pursuing over 100 company-sponsored clinical studies with the participation of thousands of patients in 60 countries around the globe.

> Breakthrough Innovations
> R&D Focus and Vision

The people behind the research
Tapping into the creativity of the best scientific minds is the key to EMD Serono's innovation strategy.
> Scientist Profiles

Download

Fact sheet Research Excellence (166 KB)

PIPELINE

Our current Pipeline

SERVICES

Request Medical Information

Print Page

Request Medical Information

Disclaimer

This site contains medical information that is intended for residents of the United States only and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy.

This site contains information that is intended for US residents only. Canadian residents should consult the EMD Serono Canada Inc. website at www.emdserono.ca for information on products and services approved in Canada.